These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33679090)

  • 21. Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia.
    Al-Arifi MN
    Saudi Pharm J; 2013 Oct; 21(4):351-60. PubMed ID: 24227954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community pharmacists' perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China.
    Song M; Ung CO; Lee VW; Hu Y; Zhao J; Li P; Hu H
    BMC Complement Altern Med; 2017 Jan; 17(1):9. PubMed ID: 28056935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of knowledge base of hospital pharmacists and physicians on herbal medicines in Southwestern Nigeria.
    Fakeye TO; Onyemadu O
    Pharm Pract (Granada); 2008 Apr; 6(2):88-92. PubMed ID: 25157286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Community pharmacists' views on adverse drug reactions reporting in Malaysia: a pilot study.
    Ting KN; Stratton-Powell DM; Anderson C
    Pharm World Sci; 2010 Jun; 32(3):339-42. PubMed ID: 20336371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community pharmacists' knowledge, behaviors and experiences about adverse drug reaction reporting in Saudi Arabia.
    Mahmoud MA; Alsowaida Y; Alshammari T; Khan TM; Alrasheedy A; Hassali MA; Aljadhey H
    Saudi Pharm J; 2014 Nov; 22(5):411-8. PubMed ID: 25473329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacist's knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Suyagh M; Farah D; Abu Farha R
    Saudi Pharm J; 2015 Apr; 23(2):147-53. PubMed ID: 25972734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacists' attitudes towards the reporting of suspected adverse drug reactions in Norway.
    Granas AG; Buajordet M; Stenberg-Nilsen H; Harg P; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):429-34. PubMed ID: 16953518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community pharmacists' perceptions of services that benefit older people in New Zealand.
    Tordoff J; Chang SY; Norris PT
    Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of community pharmacists' knowledge and awareness of food-drug interactions in Palestine.
    Radwan A; Sweileh A; Shraim W; Hroub A; Elaraj J; Shraim N
    Int J Clin Pharm; 2018 Jun; 40(3):668-675. PubMed ID: 29721737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced knowledge of spontaneous reporting with structured educational programs in Korean community pharmacists: a cross-sectional study.
    Yu YM; Lee E
    BMC Med Educ; 2017 May; 17(1):95. PubMed ID: 28558681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.
    Cheema E; Haseeb A; Khan TM; Sutcliffe P; Singer DR
    Pharm Pract (Granada); 2017; 15(3):931. PubMed ID: 28943977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors that facilitate reporting of adverse drug reactions by pharmacists in Saudi Arabia.
    Aldryhim AY; Alomair A; Alqhtani M; Mahmoud MA; Alshammari TM; Pont LG; Kamal KM; Aljadhey H; Mekonnen AB; Alwhaibi M; Balkhi B; Alhawassi TM
    Expert Opin Drug Saf; 2019 Aug; 18(8):745-752. PubMed ID: 31232612
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis.
    Barrett R
    BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perceptions, opinions and knowledge of pharmacists towards the use of complementary medicines by people living with cancer.
    Harnett J; Le TQ; Smith L; Krass I
    Int J Clin Pharm; 2018 Oct; 40(5):1272-1280. PubMed ID: 29744793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Community pharmacists' knowledge and perceptions about adverse drug reactions and barriers towards their reporting in Eastern region, Alahsa, Saudi Arabia.
    Khan TM
    Ther Adv Drug Saf; 2013 Apr; 4(2):45-51. PubMed ID: 25083250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with the intention of community pharmacists to report adverse drug reactions to regulatory authority in Malaysia: application of the theory of planned behaviour.
    Raghvan HPN; Fatokun O
    Int J Pharm Pract; 2021 Oct; 29(5):435-442. PubMed ID: 34244775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge and characteristics of herbal supplement usage among community pharmacy customers in a Malaysian population.
    Yeong SW; Choong YC
    Complement Ther Med; 2017 Dec; 35():92-108. PubMed ID: 29154074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community pharmacists' knowledge, attitudes and practices towards herbal remedies in Riyadh, Saudi Arabia.
    Alkharfy KM
    East Mediterr Health J; 2010 Sep; 16(9):988-93. PubMed ID: 21218728
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists' attitudes towards an evidence-based approach for over-the-counter medication.
    Hanna LA; Hughes CM
    Int J Clin Pharm; 2012 Feb; 34(1):63-71. PubMed ID: 22108790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.